| Mr Jonathan D Briggs, FNP-BC | |
|
4300 Highway 90, Conway, SC 29526-9630 | |
| (843) 399-3377 | |
| (843) 399-3378 |
| Full Name | Mr Jonathan D Briggs |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 30 Years |
| Location | 4300 Highway 90, Conway, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053380220 | NPI | - | NPPES |
| NP6994 | Medicaid | SC | |
| 01503759 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 23989 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Conway Medical Center | Conway, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Conway Hospital Inc | 7113839606 | 98 |
News Archive
GlaxoSmithKline announced today that it is implementing changes to the US product label for Avandia(R) (rosiglitazone maleate), based on an extensive and thorough review by the FDA of myocardial ischemia data on Avandia, the most widely studied oral anti-diabetic medicine available.
Scientists from Singapore, China and USA have identified three new susceptibility genes in a genome-wide association study of nasopharyngeal carcinoma (NPC). The study, led by the Genome Institute of Singapore (GIS), a biomedical research institute of the Agency for Science, Technology and Research (A*STAR), and the Sun Yat-Sen University Cancer Centre, identified genetic risk factors of NPC that advance the understanding of the important role played by host genetic variation in influencing the susceptibility to this cancer.
AdvanSource Biomaterials Corporation, a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced that it has received a "Notice of Allowance" from the U.S. Patent and Trademark Office in connection with its antimicrobial patent application filed in June 2007. U.S. Patent No. 7,772,296, which is entitled "Antimicrobial Polyurethane Resins and Products Made Therefrom," covers a drug-free, antimicrobial technology to eradicate Methicillin-resistant Staphylococcus aureus ("MRSA") clinical infections associated with medical devices.
One California partnership that involved a large insurance company, a major hospital chain and a group of doctors has reduced health care costs. But a new report shows that the growing number of hospital-based physicians may ultimately be taxing Medicare resources.
› Verified 5 days ago
| Entity Name | Conway Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134172000 PECOS PAC ID: 7113839606 Enrollment ID: O20031201000111 |
News Archive
GlaxoSmithKline announced today that it is implementing changes to the US product label for Avandia(R) (rosiglitazone maleate), based on an extensive and thorough review by the FDA of myocardial ischemia data on Avandia, the most widely studied oral anti-diabetic medicine available.
Scientists from Singapore, China and USA have identified three new susceptibility genes in a genome-wide association study of nasopharyngeal carcinoma (NPC). The study, led by the Genome Institute of Singapore (GIS), a biomedical research institute of the Agency for Science, Technology and Research (A*STAR), and the Sun Yat-Sen University Cancer Centre, identified genetic risk factors of NPC that advance the understanding of the important role played by host genetic variation in influencing the susceptibility to this cancer.
AdvanSource Biomaterials Corporation, a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced that it has received a "Notice of Allowance" from the U.S. Patent and Trademark Office in connection with its antimicrobial patent application filed in June 2007. U.S. Patent No. 7,772,296, which is entitled "Antimicrobial Polyurethane Resins and Products Made Therefrom," covers a drug-free, antimicrobial technology to eradicate Methicillin-resistant Staphylococcus aureus ("MRSA") clinical infections associated with medical devices.
One California partnership that involved a large insurance company, a major hospital chain and a group of doctors has reduced health care costs. But a new report shows that the growing number of hospital-based physicians may ultimately be taxing Medicare resources.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jonathan D Briggs, FNP-BC 300 Singleton Ridge Road, Attention Pns Credentialing, Conway, SC 29526-9142 Ph: (843) 234-6946 | Mr Jonathan D Briggs, FNP-BC 4300 Highway 90, Conway, SC 29526-9630 Ph: (843) 399-3377 |
News Archive
GlaxoSmithKline announced today that it is implementing changes to the US product label for Avandia(R) (rosiglitazone maleate), based on an extensive and thorough review by the FDA of myocardial ischemia data on Avandia, the most widely studied oral anti-diabetic medicine available.
Scientists from Singapore, China and USA have identified three new susceptibility genes in a genome-wide association study of nasopharyngeal carcinoma (NPC). The study, led by the Genome Institute of Singapore (GIS), a biomedical research institute of the Agency for Science, Technology and Research (A*STAR), and the Sun Yat-Sen University Cancer Centre, identified genetic risk factors of NPC that advance the understanding of the important role played by host genetic variation in influencing the susceptibility to this cancer.
AdvanSource Biomaterials Corporation, a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced that it has received a "Notice of Allowance" from the U.S. Patent and Trademark Office in connection with its antimicrobial patent application filed in June 2007. U.S. Patent No. 7,772,296, which is entitled "Antimicrobial Polyurethane Resins and Products Made Therefrom," covers a drug-free, antimicrobial technology to eradicate Methicillin-resistant Staphylococcus aureus ("MRSA") clinical infections associated with medical devices.
One California partnership that involved a large insurance company, a major hospital chain and a group of doctors has reduced health care costs. But a new report shows that the growing number of hospital-based physicians may ultimately be taxing Medicare resources.
› Verified 5 days ago
Mrs. Danielle Karin Brown, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 251 University Blvd, Conway, SC 29526 Phone: 843-349-6543 | |
Linda Lee Queen, ARPN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1608 Main St, Conway, SC 29526 Phone: 843-248-4700 Fax: 843-248-3145 | |
Dr. Karen Jeanette Smith, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2996 E Highway 501, Conway, SC 29526 Phone: 843-347-2613 | |
Betsy L Paul, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1113 Church St, Conway, SC 29526 Phone: 843-248-6269 | |
Diana L Taylor, DNP, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 140 Professional Park Drive, Conway, SC 29526 Phone: 843-234-5678 | |
Anooja Nair, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 834 Farrar Dr, Conway, SC 29526 Phone: 843-497-7275 |